✨ Unlock Data Exports And Disclosure Access.Start Your 30-Day Free Trial Today →

Merck & Co Inc

Country
United States
Sector
Healthcare
Industry
Drug Manufacturers - General
Employees
73,000
Ticker
MRK
Exchange
New York Stock Exchange
Description
Merck & Co., Inc. operates as a leading healthcare company worldwide, specializing in the research, development, and commercialization of innovative pharmaceutical products and vaccines. Its portfolio...

Merck & Co Inc's GHG Emissions Data Preview

In 2024, Merck & Co Inc completed a corporate carbon footprint assessment and publicly disclosed its greenhouse gas (GHG) emissions according to the GHG Protocol, covering Scope 1 (direct emissions from owned or controlled sources), Scope 2 (indirect emissions from purchased energy) and Scope 3 (indirect emissions across the value chain).

Merck & Co Inc has also provided a category-level breakdown for 11 out of 15 Scope 3 emissions categories, offering greater transparency into its value chain emissions.

Metric (tCO2e)2024202320222021-2019
Total Scope 1
721,200a
731,600a
739,500a
Total Scope 2
Market-Based
163,000a
170,100a
217,300a
Location-Based
323,800a
340,400a
350,500a
Total Scope 3
6,057,900a
5,863,500a
5,999,600a
Total Scope 1 Revenue Intensity (tCO2e/$M)
11.2392a
12.17a
12.4741a
Usage Policy

You are welcome to quote or reference individual data points from this page, provided you include the following attribution with a visible, clickable link to this page: "Source: Tracenable, the global reference for ESG data"

Bulk collection, scraping, resale, or redistribution of data across multiple company profiles is not permitted without our prior written permission. For more information, see our General Terms and Conditions.

Access Datasets, Disclosures, and Sources
pro
Remove manual data sourcing from your workflow. Subscribe to Tracenable Pro to get credits for accessing and exporting datasets and disclosures across 8,500+ companies with 10+ years of historical coverage.
Download granular datasets (CSV/XLS)
Access underlying corporate disclosures (PDF)
Trace all values back to their original sources
Formats Included
Excel
CSV
Json
All data fully traceable to original sources
Used by 1,000+ teams in finance, climate, and research
Access this data via API
$curl "https://tracenable.com/api/v1/ghg-emissions/absolute?ticker=MRK&reporting_period=2024"

Verified Sources Behind Merck & Co Inc’s Greenhouse Gas (GHG) Emissions Data

Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform.

a. Merck & Co Inc's Impact Report 2025

Insights into Merck & Co Inc's Operational Emissions

In 2024, the total operational greenhouse gas (GHG) emissions of Merck & Co Inc amounted to 1,045,000 metric tons of CO2 equivalent. This figure includes both direct emissions from owned or controlled sources (Scope 1) and indirect emissions from purchased energy (Scope 2).a

Compared to 2023, the total operational greenhouse gas (GHG) emissions of Merck & Co Inc decreased by 2.52%, showing that the company has made progress in taking action to reduce the climate impact of its operations.a

Merck & Co Inc's Scope 1 Emissions Over Time

2019202020212022202320240200 k400 k600 k800 ktCO2e-1%-4%+5%-1%-1%
  • Total Scope 1
  • Year-over-Year Change

What are Merck & Co Inc's Scope 1 emissions?

In 2024, the total Scope 1 emissions of Merck & Co Inc were 721,200 metric tons of CO₂ equivalent (tCO₂e).a

Has Merck & Co Inc reduced its Scope 1 emissions over time?

Since 2019, Merck & Co Inc's Scope 1 emissions have decreased by 3.44%, reflecting a declining long-term trend in Scope 1 emissions over time.a

Compared to the previous year (2023), Merck & Co Inc's Scope 1 emissions decreased by 1.42%, highlighting the company's efforts to lower direct emissions from assets it owns or controls.a

What are Merck & Co Inc's Scope 2 emissions?

In 2024, Merck & Co Inc reported Scope 2 greenhouse gas (GHG) emissions of 163,000 tCO₂e using the market-based method and 323,800 tCO₂e using the location-based method.a

Has Merck & Co Inc reduced its Scope 2 emissions over time?

Since 2019, Merck & Co Inc's Scope 2 greenhouse gas (GHG) emissions (Location-Based) have decreased by 13.75%, reflecting a declining long-term trend in Scope 2 emissions over time.a

Compared to the previous year (2023), Merck & Co Inc's Scope 2 emissions (Location-Based) have remained relatively stable, indicating that Merck & Co Inc's emissions have plateaued with no significant change in its energy consumption footprint.a

What methodology does Merck & Co Inc use for Scope 2 reporting?

In 2024, Merck & Co Inc reported its Scope 2 emissions using the market-based method and using the location-based method.a

Merck & Co Inc's Scope 2 Emissions Over Time

201920202021202220232024095 k190 k285 k380 ktCO2e
  • Total Scope 2 Location-Based
  • Total Scope 2 Market-Based

Insights into Merck & Co Inc's Value Chain Emissions

In 2024, Merck & Co Inc reported 6,057,900 metric tons of CO₂ equivalent (tCO₂e) of Scope 3 greenhouse gas (GHG) emissions, representing indirect emissions across its upstream and downstream value chain.a

The 2024 disclosure of Merck & Co Inc includes a breakdown across 11 of the 15 Scope 3 categories defined by the GHG Protocol, matching the level of disclosure in 2023, demonstrating consistent Scope 3 emissions reporting coverage year over year.a

Merck & Co Inc's Scope 3 Emissions Over Time

20192020202120222023202402 M4 M6 M8 MtCO2e-4%+1%-4%-2%+3%
  • Total Scope 3
  • Year-over-Year Change

What are Merck & Co Inc's Scope 3 emissions?

In 2024, Merck & Co Inc reported total Scope 3 emissions of 6,057,900 metric tons of CO₂ equivalent (tCO₂e).a

Approximately 99.5% of these emissions originated from upstream activities such as purchased goods and capital goods, while 0.5% came from downstream activities like product use, distribution, and end-of-life treatment.a

Has Merck & Co Inc reduced its Scope 3 emissions over time?

Since 2019, Merck & Co Inc's Scope 3 emissionshave remained relatively stable, indicating that Merck & Co Inc's emissions have plateaued with no significant change in its value chain footprint.a

Compared to the previous year (2023), Merck & Co Inc's Scope 3 emissions remained relatively stable, indicating that Merck & Co Inc's emissions have plateaued with no significant change in its value chain footprint.a

What categories of Scope 3 emissions does Merck & Co Inc disclose?

In 2024, Merck & Co Inc reported emissions for 11 out of the 15 Scope 3 categories defined by the GHG Protocol.a

This reflects a high level of granularity and transparency in the company's emissions reporting.

What are the main sources of Merck & Co Inc's Scope 3 emissions?

In 2024, the largest contributors to Merck & Co Inc's Scope 3 emissions were:a

  • Purchased Goods and Services (Cat. 1): 4,743,200 tCO₂e (78.3%)
  • Upstream Transportation and Distribution (Cat. 4): 423,700 tCO₂e (6.99%)
  • Capital Goods (Cat. 2): 281,700 tCO₂e (4.65%)

Merck & Co Inc's Scope 3 Emissions by Categories

Purchased Goods andServices (Cat. 1)(78.3%)Capital Goods(Cat. 2)(4.7%)UpstreamTransportation andDistribution(Cat. 4)(7.0%)

Insights into Merck & Co Inc’s GHG Emissions Intensity Compared to Industry Peers

In 2024, Merck & Co Inc reported Scope 1 greenhouse gas (GHG) emissions of 721,200 tCO₂e and total revenues of USD 64,168 millions. This translates into an emissions intensity of 11.24 tCO₂e per millions USD.a

Merck & Co Inc's Scope 1 Emissions Intensity Compared to Peers

5005,00050,000500,00010,000,000Scope 1 Emissions (tCO2e)2002,00010,00050,000200,000Revenues (Millions of USD)Orion OyjYear: 2025Scope 1: 5,018 tCO2eRevenue: $M 2,221Scope 1 Intensity: 2.26 tCO2e/$MCspc Pharmaceutical GroupYear: 2024Scope 1: 474,567 tCO2eRevenue: $M 3,975Scope 1 Intensity: 119.39 tCO2e/$MRecordatiYear: 2025Scope 1: 36,557 tCO2eRevenue: $M 3,078Scope 1 Intensity: 11.88 tCO2e/$MZhangzhou Pientzehuang PharmaceuticalYear: 2023Scope 1: 2,301 tCO2eRevenue: $M 1,415Scope 1 Intensity: 1.63 tCO2e/$MAstellas PharmaYear: 2024Scope 1: 52,212 tCO2eRevenue: $M 10,589Scope 1 Intensity: 4.93 tCO2e/$MOtsuka HoldingsYear: 2024Scope 1: 368,733 tCO2eRevenue: $M 14,840Scope 1 Intensity: 24.85 tCO2e/$MDaiichi SankyoYear: 2024Scope 1: 91,836 tCO2eRevenue: $M 10,576Scope 1 Intensity: 8.68 tCO2e/$MChugai PharmaceuticalYear: 2024Scope 1: 51,143 tCO2eRevenue: $M 7,456Scope 1 Intensity: 6.86 tCO2e/$MAbbott LaboratoriesYear: 2025Scope 1: 499,000 tCO2eRevenue: $M 44,328Scope 1 Intensity: 11.26 tCO2e/$MThermo Fisher ScientificYear: 2024Scope 1: 315,843 tCO2eRevenue: $M 42,879Scope 1 Intensity: 7.37 tCO2e/$MBayerYear: 2025Scope 1: 1,890,000 tCO2eRevenue: $M 53,581Scope 1 Intensity: 35.27 tCO2e/$MGSKYear: 2024Scope 1: 521,000 tCO2eRevenue: $M 39,374Scope 1 Intensity: 13.23 tCO2e/$MNovo NordiskYear: 2025Scope 1: 120,000 tCO2eRevenue: $M 48,646Scope 1 Intensity: 2.47 tCO2e/$MAstraZenecaYear: 2024Scope 1: 125,386 tCO2eRevenue: $M 54,074Scope 1 Intensity: 2.32 tCO2e/$MNovartisYear: 2024Scope 1: 207,000 tCO2eRevenue: $M 40,180Scope 1 Intensity: 5.15 tCO2e/$MRoche HoldingYear: 2025Scope 1: 211,962 tCO2eRevenue: $M 79,968Scope 1 Intensity: 2.65 tCO2e/$MOrganon & CoYear: 2024Scope 1: 34,200 tCO2eRevenue: $M 6,403Scope 1 Intensity: 5.34 tCO2e/$MBiogenYear: 2024Scope 1: 56,611 tCO2eRevenue: $M 9,676Scope 1 Intensity: 5.85 tCO2e/$MGilead SciencesYear: 2024Scope 1: 53,856 tCO2eRevenue: $M 28,754Scope 1 Intensity: 1.87 tCO2e/$MBristol-Myers SquibbYear: 2024Scope 1: 206,726 tCO2eRevenue: $M 48,300Scope 1 Intensity: 4.28 tCO2e/$MPfizerYear: 2024Scope 1: 613,218 tCO2eRevenue: $M 63,627Scope 1 Intensity: 9.64 tCO2e/$MJohnson & JohnsonYear: 2024Scope 1: 314,690 tCO2eRevenue: $M 88,820Scope 1 Intensity: 3.54 tCO2e/$MEli Lilly and CoYear: 2024Scope 1: 192,000 tCO2eRevenue: $M 45,043Scope 1 Intensity: 4.26 tCO2e/$MAmgenYear: 2024Scope 1: 147,000 tCO2eRevenue: $M 33,424Scope 1 Intensity: 4.40 tCO2e/$MAbbvieYear: 2025Scope 1: 304,649 tCO2eRevenue: $M 61,160Scope 1 Intensity: 4.98 tCO2e/$MMerck & Co IncYear: 2024Scope 1: 721,200 tCO2eRevenue: $M 64,168Scope 1 Intensity: 11.24 tCO2e/$M

How does Merck & Co Inc's GHG emissions intensity compare to its peers?

In 2024, Merck & Co Inc reported a Scope 1 emissions intensity of 11.24 tCO₂e per millions USD. Compared to the peer group median of 5.15, this places the company above its industry benchmark, indicating it is less carbon-efficient than most competitors.a

Where does Merck & Co Inc rank on GHG emissions intensity within its industry?

In 2024, Merck & Co Inc ranked 20 out of 25 companies in its industry peer group, based on Scope 1 emissions intensity (measured in tCO₂e per millions USD).a

Merck & Co Inc is therefore positioned in the mid-range of its industry, neither a clear leader nor a laggard in carbon efficiency.a

Insights into Merck & Co Inc's Total Carbon Footprint

In 2024, Merck & Co Inc reported a total carbon footprint of 7,102,900 metric tons of CO₂ equivalent (tCO₂e) across Scope 1, Scope 2, and Scope 3 emissions. This represents a 2.41% increase compared to 2023, suggesting a rise in emissions across its operations or value chain.a

The largest contributor to Merck & Co Inc's total carbon footprint was Scope 3 emissions, accounting for 85.29% of the company's total carbon footprint, followed by Scope 1 emissions at 10.15%.a

Want Full Access to Merck & Co Inc's GHG Emissions Dataset?
Start 30-Day Free Trial